The Look at any Localized Trust Group Networks Trillion Hearts Software

From World News
Jump to navigation Jump to search

Further work on the algorithm will include accurate parameterization of the algorithm's window size.
Observer studies in pathology often utilize a limited number of representative slides per case, selected and reported in a nonstandardized manner. Vacuolin-1 Reference diagnoses are commonly assumed to be generalizable to all slides of a case. We examined these issues in the context of pathologist concordance for histologic subtype classification of ovarian carcinomas (OCs).
A cohort of 114 OCs consisting of 72 cases with a single representative slide (Group 1) and 42 cases with multiple representative slides (148 slides, 2-6 sections per case, Group 2) was independently reviewed by three experts in gynecologic pathology (case-based review). In a follow-up study, each individual slide was independently reviewed in a randomized order by the same pathologists (section-based review).
Average interobserver concordance varied from 100% for Group 1 to 64.3% for Group 2 (86.8% across all cases). Across Group 2, 19 cases (45.2%) had at least one slide classified as a different subtype than the subtype assigned from case-bcted to evaluate artificial intelligence/machine learning tools, can influence diagnostic performance, and if not accounted for, can cause disparities between research and real-world observations and between research studies. Case selection in validation studies should account for tumor heterogeneity to create balanced datasets in terms of diagnostic complexity.Modern image analysis techniques based on artificial intelligence (AI) have great potential to improve the quality and efficiency of diagnostic procedures in pathology and to detect novel biomarkers. Despite thousands of published research papers on applications of AI in pathology, hardly any research implementations have matured into commercial products for routine use. Bringing an AI solution for pathology to market poses significant technological, business, and regulatory challenges. In this paper, we provide a comprehensive overview and advice on how to meet these challenges. We outline how research prototypes can be turned into a product-ready state and integrated into the IT infrastructure of clinical laboratories. We also discuss business models for profitable AI solutions and reimbursement options for computer assistance in pathology. Moreover, we explain how to obtain regulatory approval so that AI solutions can be launched as in vitro diagnostic medical devices. Thus, this paper offers computer scientists, software companies, and pathologists a road map for transforming prototypes of AI solutions into commercial products.Among the paradigms changed by the COVID-19 pandemic is the traditional academic and educational conference. In the vein of turning lemons into lemonade, many organizations and individuals have discovered ways that this public health necessitated change can be transformed into a boon to both participants and organizations. However, the question of whether this shift becomes permanent, or a component of the future of academic and educational meetings remains to be seen, and likely will depend on the solution to some of the challenges that have not been sweetened by the shift. This editorial draws on experience with a limited scope of virtual meetings in two different disciplines to make the case that the Virtual Mega-Conference is likely to continue to be a part of life in the years ahead.The European Society for Digital and Integrative Pathology (ESDIP) was formally founded in 2016 in Berlin. After a well-participated annual general meeting, ESDIP members elected a new active structure for the next term of office. The priority goals of this new and highly motivated team will be to support the digital transformation in the pathology laboratories, to build inter-institutional bridges for cooperation, to establish a solid educational program, and to increase the collaboration with industry partners.
The development of artificial intelligence (AI) in pathology frequently relies on digitally annotated whole slide images (WSI). The creation of these annotations - manually drawn by pathologists in digital slide viewers - is time consuming and expensive. At the same time, pathologists routinely annotate glass slides with a pen to outline cancerous regions, for example, for molecular assessment of the tissue. These pen annotations are currently considered artifacts and excluded from computational modeling.
We propose a novel method to segment and fill hand-drawn pen annotations and convert them into a digital format to make them accessible for computational models. Our method is implemented in Python as an open source, publicly available software tool.
Our method is able to extract pen annotations from WSI and save them as annotation masks. On a data set of 319 WSI with pen markers, we validate our algorithm segmenting the annotations with an overall Dice metric of 0.942, Precision of 0.955, and Recall of 0.943. Processing all images takes 15 min in contrast to 5 h manual digital annotation time. Further, the approach is robust against text annotations.
We envision that our method can take advantage of already pen-annotated slides in scenarios in which the annotations would be helpful for training computational models. We conclude that, considering the large archives of many pathology departments that are currently being digitized, our method will help to collect large numbers of training samples from those data.
We envision that our method can take advantage of already pen-annotated slides in scenarios in which the annotations would be helpful for training computational models. We conclude that, considering the large archives of many pathology departments that are currently being digitized, our method will help to collect large numbers of training samples from those data.
Recently, research data are increasingly shared through social media and other digital platforms. Traditionally, the influence of a scientific article has been assessed by the publishing journal's impact factor (IF) and its citation count. The Altmetric scoring system, a new bibliometric that integrates research "mentions" over digital media platforms, has emerged as a metric of online research distribution. The aim of this study was to explore the relationship of the Altmetric Score with IF and citation number within the pathology literature.
Citation count and Altmetric scores were obtained from the top 10 most-cited articles from the 15 pathology journals with the highest IF for 2013 and 2016. These variables were analyzed and correlated with each other, as well as the age of the publishing journal's Twitter account.
Three hundred articles were examined from the two cohorts. The total citation count of the articles decreased from 21,043 (2013) to 14,679 (2016), while the total Altmetric score increased from 830 (2013) to 4066 (2016).